(Total Views: 74)
Posted On: 07/22/2019 11:05:44 AM
Post# of 21264

$TBPH News Article - Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology Congress https://marketwirenews.com/news-releases/ther...11366.html


My Twitter: WhyteStocks